Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
SciSparc Ltd. ( (SPRC) ) just unveiled an announcement.
SciSparc Ltd. has announced its Annual General Meeting of Shareholders, scheduled for June 25, 2025, in Tel Aviv, Israel. The meeting will address several key proposals, including the re-election of directors, an increase in authorized share capital, a potential reverse stock split, and the re-adoption of the compensation policy for executives. Shareholders of record as of May 27, 2025, are eligible to vote on these matters. The outcomes of these proposals could significantly impact SciSparc’s corporate governance and financial structure, potentially influencing its market positioning and stakeholder interests.
More about SciSparc Ltd.
SciSparc Ltd. operates in the biotechnology industry, focusing on the development of therapies for central nervous system disorders. The company is based in Tel Aviv, Israel, and engages in the research and development of cannabinoid-based therapies.
Average Trading Volume: 4,037,081
Technical Sentiment Signal: Sell
Current Market Cap: $3.26M
See more insights into SPRC stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue